ARCT

Arcturus Therapeutics Holdings Inc.

Price

$14.66

return (12m)

-15.26%

p/e

-4.30

p/bv

2.34

DIVIDEND YIELD

0.00%

ARCT price

Arcturus Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ARCT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

155.18%

3 months

85.10%

1 year

-15.26%

2 years

-29.65%

5 years

-72.68%

10 years

-57.43%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ARCT

Valuation

P/E

-4.30

Sector -4.26

Industry -4.26

P/BV

2.34

Sector 2.11

Industry 2.11

P/Revenue (PSR)

13.67

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

1.79

Sector 1.25

Industry 1.25

P/Net Current Assets

2.78

Sector -5.47

Industry -5.47

P/Working Capital

2.45

Sector -1.10

Industry -1.10

EPS

-3.33

Sector -1.94

Industry -1.94

BVPS

6.14

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

100.00%

Sector 38.90%

Industry 38.90%

EBITDA Margin

0.00%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

0.00%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-100.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

-100.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.01

Sector 0.03

Industry 0.03

Profitability

ROE

-54.29%

Sector -61.50%

Industry -61.50%

ROA

-41.59%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

5.88

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.77

Sector 0.43

Industry 0.43

Liabilities/Assets

0.23

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

18.90%

Sector -

Industry -

5Y Earnings CAGR

-14.46%

Sector -

Industry -

Fundamentals ARCT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ARCT Arcturus Therapeutics Holdings Inc.	$14.66	-15.21%	0.00%	-4.30	2.34	-54.29%	-100.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ARCT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Arcturus Therapeutics

Arcturus Therapeutics Holdings Inc.

Average Investor10 user rating

4.0 (2 people)

United States

18 years

Founded: 2008

Time since IPO - - year

88

Employees

Arcturus Therapeutics Holdings Inc. (United States) is listed on the Nasdaq and has a market capitalization of $401.52 million, with shareholders equity totaling $171.81 million.

The company employs approximately 88 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Arcturus Therapeutics Holdings Inc. reported $29.37 million in revenue, generating net income of $-93.28 million.

Key financial metrics include a P/E ratio of -4.30, a price-to-book (P/B) ratio of 2.34, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARCT.

Market cap

$401.52 million

Net worth

$171.81 million

$171,810,000.00

Assets

$224.31 million

$224,310,000.00

Total Shares Outstanding

28.00 million

28,000,000

Average Daily Trading Volume

Sector

Health Care

Industry

Biotechnology

ARCT

ARCT revenue and profits

Financial Results ARCT

DRAG THE FRAME TO SEE MORE DATA

ARCT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Arcturus Therapeutics (ARCT) today?

A cotação de Arcturus Therapeutics (ARCT) hoje está em US$ 14.66, com uma variação de -15.26% em relação ao último ano. A cotação de Arcturus Therapeutics (ARCT) iniciou o ano negociando na casa dos US$ 6.13 e hoje está em US$ 14.66. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Arcturus Therapeutics (ARCT) e dados de ações do Ibovespa e mercados internacionais.

Quando Arcturus Therapeutics (ARCT) paga dividendos?

Arcturus Therapeutics (ARCT) não distribuiu dividendos no último ano.

Is Arcturus Therapeutics (ARCT) a good investment?

Atualmente, Arcturus Therapeutics (ARCT) está cotada a US$ 14.66, com um P/L de -4.30, representando um desvio de -1,454% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -15.26 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -15.26%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Arcturus Therapeutics (ARCT) stock?

Investir em ações de Arcturus Therapeutics (ARCT) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Arcturus Therapeutics (ARCT) yield today?

A rentabilidade de Arcturus Therapeutics (ARCT) foi de 155.18% no último mês, -15.26% no último ano e -72.68% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Arcturus Therapeutics (ARCT) hoje, o investimento total seria de US$ 1,466.00, com base na cotação atual de US$ 14.66.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,242.29
Em 5 anos: US$ 400.51
Em 10 anos: US$ 624.08

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ARCT

Arcturus Therapeutics Holdings Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ARCT

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ARCT WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Arcturus Therapeutics

Arcturus Therapeutics Holdings Inc.

United States

18 years

88

PROFIT X PRICE ARCT

Financial Results ARCT

ARCT cash flow

Asset, Revenue and Profit Growth - ARCT

ARCT balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions